AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 26803595 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (1000 mg DHA; 200 mg EPA)
Number of subjects: 94
Study 26803595 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA supplementation (1000 mg EPA; 200 mg DHA)
Number of subjects: 94
Study 26803595 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sunola oil)
Number of subjects: 94
Study 23989707 — intervention group
Group type: COMPARATOR
Intervention: Conventional instrumentation (group A)
Number of subjects: 45
Study 23989707 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-specific instrumentation (group B)
Number of subjects: 45
Study 25276669 — intervention group
Group type: EXPERIMENTAL
Intervention: Chart presenting pregnancy risk with combined pills
Number of subjects: 630
Study 25276669 — intervention group
Group type: EXPERIMENTAL
Intervention: Chart presenting pregnancy risk with intrauterine devices
Number of subjects: 630
Study 25276669 — intervention group
Group type: EXPERIMENTAL
Intervention: Chart presenting pregnancy risk with condoms
Number of subjects: 630
Study 20155788 — intervention group
Group type: EXPERIMENTAL
Intervention: Hémoionic
Number of subjects: 85
Study 20155788 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 85
Study 17629087 — intervention group
Group type: EXPERIMENTAL
Intervention: CA 72-4
Number of subjects: 47
Study 16258100 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Assessment of Cancer Treatment-Fatigue scores
Number of subjects: 104
Study 16258100 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Assessment of Cancer Treatment-Endocrine Symptoms scores
Number of subjects: 104
Study 16258100 — intervention group
Group type: EXPERIMENTAL
Intervention: Incidence of moderate-severe cognitive dysfunction by High Sensitivity Cognitive Screen
Number of subjects: 104
Study 16258100 — intervention group
Group type: COMPARATOR
Intervention: Quality of life differences between patients and controls
Number of subjects: 104
Study 12114419 — intervention group
Group type: EXPERIMENTAL
Intervention: ISIS 3521 (2 mg/kg/day as continuous i.v. infusion for 21 of 28 days)
Number of subjects: 37
Study 12114419 — intervention group
Group type: EXPERIMENTAL
Intervention: ISIS 5132 (2 mg/kg/day as continuous i.v. infusion for 21 of 28 days)
Number of subjects: 37
Study 10198937 — intervention group
Group type: EXPERIMENTAL
Intervention: Music programme guide for parents of blind children
Number of subjects: 0
Study 8673001 — intervention group
Group type: EXPERIMENTAL
Intervention: Beta-carotene supplementation (30 mg/day) for up to 2 years
Number of subjects: 0
Study 8673001 — intervention group
Group type: COMPARATOR
Intervention: Control group (without beta-carotene supplementation)
Number of subjects: 0
Study 2181856 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose polymer Polycose (100 or 150 g daily for 6 months)
Number of subjects: 21
Study 2181856 — intervention group
Group type: COMPARATOR
Intervention: Control (no energy supplementation)
Number of subjects: 21
Study 7194063 — intervention group
Group type: EXPERIMENTAL
Intervention: etofylline clofibrate (Duolip) treatment
Number of subjects: 221
Study 31539578 — intervention group
Group type: EXPERIMENTAL
Intervention: Garner task for PS
Number of subjects: 70
Study 31539578 — intervention group
Group type: EXPERIMENTAL
Intervention: Garner task for ED
Number of subjects: 70
Study 31539578 — intervention group
Group type: EXPERIMENTAL
Intervention: Reaction time analysis
Number of subjects: 70
Study 30241990 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 (EPA 740 mg and DHA 400 mg daily)
Number of subjects: 50
Study 30241990 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 26886460 — intervention group
Group type: EXPERIMENTAL
Intervention: Brace treatment (thoracolumbosacral orthosis, at least 18 h/d)
Number of subjects: 167
Study 25862546 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetaminophen
Number of subjects: 0
Study 25862546 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22822191 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced air warming
Number of subjects: 1
Study 22822191 — intervention group
Group type: EXPERIMENTAL
Intervention: Conductive fabric warming
Number of subjects: 1
Study 22822191 — intervention group
Group type: COMPARATOR
Intervention: Control conditions
Number of subjects: 1
Study 21419288 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:100,000 epinephrine
Number of subjects: 86
Study 21419288 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% articaine with 1:200,000 epinephrine
Number of subjects: 86
Study 19526752 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (Xinyue Capsule and compound Tanshinon Tablet)
Number of subjects: 80
Study 19526752 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional Western medicine alone)
Number of subjects: 80
Study 18190583 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry capsules (108 mg)
Number of subjects: 8
Study 18190583 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry capsules (36 mg)
Number of subjects: 8
Study 18190583 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry capsules (not specified dosage)
Number of subjects: 8
Study 18190583 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 15668544 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz (EFV) 600 mg once daily
Number of subjects: 202
Study 15668544 — intervention group
Group type: EXPERIMENTAL
Intervention: nevirapine (NVP) 200 mg twice daily
Number of subjects: 202
Study 15668544 — intervention group
Group type: EXPERIMENTAL
Intervention: nevirapine (NVP) 400 mg once daily
Number of subjects: 202
Study 15668544 — intervention group
Group type: EXPERIMENTAL
Intervention: nevirapine (NVP) 400 mg once daily + efavirenz (EFV) 800 mg once daily
Number of subjects: 202
Study 15668544 — intervention group
Group type: COMPARATOR
Intervention: NVP 200 mg twice daily
Number of subjects: 202
Study 15668544 — intervention group
Group type: COMPARATOR
Intervention: EFV 600 mg once daily
Number of subjects: 202
Study 15668544 — intervention group
Group type: COMPARATOR
Intervention: NVP 400 mg once daily
Number of subjects: 202
Study 15668544 — intervention group
Group type: COMPARATOR
Intervention: NVP 400 mg once daily + EFV 800 mg once daily
Number of subjects: 202
Study 11854670 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopoly coating
Number of subjects: 10
Study 11854670 — intervention group
Group type: EXPERIMENTAL
Intervention: Permaseal coating
Number of subjects: 10
Study 11854670 — intervention group
Group type: COMPARATOR
Intervention: Control (uncoated)
Number of subjects: 10
Study 10199943 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-scintigraphy with light tablet (12 mm, different isotope)
Number of subjects: 7
Study 10199943 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamma-scintigraphy with dense tablet (12 mm, different isotope)
Number of subjects: 7
Study 10199943 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-parametric statistics (Wilcoxon test)
Number of subjects: 7
Study 10199943 — intervention group
Group type: COMPARATOR
Intervention: Commonly applied method (parametric procedures)
Number of subjects: 7
Study 7796241 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% lignocaine ointment
Number of subjects: 45
Study 7796241 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% lignocaine ointment
Number of subjects: 45
Study 7796241 — intervention group
Group type: COMPARATOR
Intervention: Control site (no treatment)
Number of subjects: 45
Study 2196496 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine screening ultrasound
Number of subjects: 915
Study 2196496 — intervention group
Group type: COMPARATOR
Intervention: Usual prenatal care
Number of subjects: 915
Study 19514 — intervention group
Group type: COMPARATOR
Intervention: Carbuterol 2 mg
Number of subjects: 8
Study 19514 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbuterol 4 mg
Number of subjects: 8
Study 19514 — intervention group
Group type: EXPERIMENTAL
Intervention: Metaproterenol 20 mg
Number of subjects: 8
Study 19514 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 31031095 — intervention group
Group type: EXPERIMENTAL
Intervention: 432 Hz tuned music
Number of subjects: 33
Study 31031095 — intervention group
Group type: COMPARATOR
Intervention: 440 Hz tuned music
Number of subjects: 33
Study 27671459 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided foam sclerotherapy (UGFS) combined with GSV high ligation
Number of subjects: 177
Study 27671459 — intervention group
Group type: COMPARATOR
Intervention: GSV stripping plus multistab avulsion or transilluminated powered phlebectomy (TIPP)
Number of subjects: 177
Study 26330362 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiopronin
Number of subjects: 82
Study 26330362 — intervention group
Group type: COMPARATOR
Intervention: Control group (no tiopronin)
Number of subjects: 82
Study 23442286 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resisted agility and repeated sprint training
Number of subjects: 20
Study 23442286 — intervention group
Group type: COMPARATOR
Intervention: Strength training
Number of subjects: 20
Study 21143465 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical niacin pretreatment with 585-nm pulsed dye laser (PDL)
Number of subjects: 18
Study 21143465 — intervention group
Group type: COMPARATOR
Intervention: 585-nm pulsed dye laser (PDL) without niacin pretreatment
Number of subjects: 18
Study 18341678 — intervention group
Group type: EXPERIMENTAL
Intervention: Eprosartan
Number of subjects: 17
Study 16492205 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (10 microg) administered at -60 min relative to a standardized breakfast meal
Number of subjects: 18
Study 16492205 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (10 microg) administered at -15 min relative to a standardized breakfast meal
Number of subjects: 18
Study 16492205 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (10 microg) administered at 0 min relative to a standardized breakfast meal
Number of subjects: 18
Study 16492205 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (10 microg) administered at +30 min relative to a standardized breakfast meal
Number of subjects: 18
Study 16492205 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (10 microg) administered at +60 min relative to a standardized breakfast meal
Number of subjects: 18
Study 16492205 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered at -15 min relative to a standardized breakfast meal
Number of subjects: 18
Study 12559646 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ganciclovir
Number of subjects: 0
Study 12559646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11194596 — intervention group
Group type: COMPARATOR
Intervention: Heart rate variability analysis (time and frequency domain measures)
Number of subjects: 25
Study 11194596 — intervention group
Group type: COMPARATOR
Intervention: Electrophysiological study
Number of subjects: 25
Study 11194596 — intervention group
Group type: COMPARATOR
Intervention: Heart rate variability analysis
Number of subjects: 25
Study 11194596 — intervention group
Group type: COMPARATOR
Intervention: Correlation analysis of autonomic tone parameters and atrial vulnerability markers
Number of subjects: 25
Study 8615351 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary linoleic acid intake
Number of subjects: 393
Study 1362038 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical stimulation of myofascial trigger points for 30 seconds
Number of subjects: 14
Study 1362038 — intervention group
Group type: COMPARATOR
Intervention: Control group (no stimulation)
Number of subjects: 14
Study 6379788 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenoterol (0.2 mg)
Number of subjects: 20
Study 6379788 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (0.4 mg)
Number of subjects: 20
Study 6379788 — intervention group
Group type: COMPARATOR
Intervention: Fenoterol (0.2 mg) and Salbutamol (0.4 mg)
Number of subjects: 20
Study 31833799 — intervention group
Group type: EXPERIMENTAL
Intervention: PepCan HPV therapeutic vaccine
Number of subjects: 31
Study 30003567 — intervention group
Group type: EXPERIMENTAL
Intervention: Telavancin
Number of subjects: 1503
Study 30003567 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 1503
Study 30003567 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 1503
Study 27021726 — intervention group
Group type: EXPERIMENTAL
Intervention: Reclaimed wastewater-irrigated produce
Number of subjects: 0
Study 27021726 — intervention group
Group type: COMPARATOR
Intervention: Fresh water-irrigated produce
Number of subjects: 0
Study 25406657 — intervention group
Group type: COMPARATOR
Intervention: Rifabutin 150 mg three times weekly (tiw)
Number of subjects: 16
Study 25406657 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifabutin 150 mg daily
Number of subjects: 16
Study 25406657 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifabutin 300 mg daily
Number of subjects: 16
Study 23080039 — intervention group
Group type: EXPERIMENTAL
Intervention: Assist-as-needed robot training
Number of subjects: 26
Study 23080039 — intervention group
Group type: COMPARATOR
Intervention: Conventional tabletop therapy
Number of subjects: 26
Study 20212343 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney transplant recipients with detectable levels of Anti-CMV IgG antibodies
Number of subjects: 150
Study 20212343 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and sex-matched individuals)
Number of subjects: 150
Study 20212343 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney transplant recipients with anti-CMV IgM antibodies
Number of subjects: 150
Study 20212343 — intervention group
Group type: COMPARATOR
Intervention: Control group (blood donors)
Number of subjects: 150
Study 20212343 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney transplant recipients with detectable MCP-1 levels
Number of subjects: 150
Study 20212343 — intervention group
Group type: EXPERIMENTAL
Intervention: Kidney transplant recipients with detectable IL-8 levels
Number of subjects: 150
Study 18596311 — intervention group
Group type: EXPERIMENTAL
Intervention: L-alanyl-L-glutamine-supplemented parenteral nutrition (PN)
Number of subjects: 44
Study 18596311 — intervention group
Group type: COMPARATOR
Intervention: Standard parenteral nutrition (PN)
Number of subjects: 44
Study 16048758 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin 1% gel once-a-day
Number of subjects: 592
Study 16048758 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin 1% solution twice-a-day
Number of subjects: 592
Study 16048758 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (placebo)
Number of subjects: 592
Study 12587340 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 8
Study 12587340 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 10356632 — intervention group
Group type: EXPERIMENTAL
Intervention: High dependence group
Number of subjects: 19
Study 10356632 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dependence group
Number of subjects: 19
Study 10356632 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 19
Study 7746978 — intervention group
Group type: EXPERIMENTAL
Intervention: Four treatment regimens
Number of subjects: 0
Study 7746978 — intervention group
Group type: EXPERIMENTAL
Intervention: Bayesian ideas
Number of subjects: 0
Study 7746978 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer simulation
Number of subjects: 0
Study 1961956 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (2 mg/kg, intravenously)
Number of subjects: 20
Study 1961956 — intervention group
Group type: COMPARATOR
Intervention: Sodium thiopental (5 mg/kg, intravenously)
Number of subjects: 20
Study 1961956 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 20
Study 1961956 — intervention group
Group type: COMPARATOR
Intervention: Sodium thiopental
Number of subjects: 20
Study 7042481 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral atenolol 25 mg
Number of subjects: 10
Study 7042481 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral atenolol 50 mg
Number of subjects: 10
Study 7042481 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral atenolol 100 mg
Number of subjects: 10
Study 7042481 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30326244 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based lifestyle intervention
Number of subjects: 60
Study 30160061 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Plus (moderate intensity; counseling by primary care clinician and a lifestyle coach)
Number of subjects: 261
Study 30160061 — intervention group
Group type: COMPARATOR
Intervention: Basic (clinician counseling only)
Number of subjects: 261
Study 30160061 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic Plus
Number of subjects: 261
Study 30160061 — intervention group
Group type: EXPERIMENTAL
Intervention: Each additional coaching visit in Basic Plus
Number of subjects: 261
Study 27861546 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous nutrition (1000 ml/24 h, 700 kcal)
Number of subjects: 100
Study 27861546 — intervention group
Group type: COMPARATOR
Intervention: Control (no intravenous nutrition)
Number of subjects: 100
Study 25322311 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified NIATx process improvement model with training in HIV services and coaching
Number of subjects: 14
Study 25322311 — intervention group
Group type: COMPARATOR
Intervention: HIV training only (control group)
Number of subjects: 14
Study 22483541 — intervention group
Group type: EXPERIMENTAL
Intervention: Below-elbow cast (BEC)
Number of subjects: 66
Study 22483541 — intervention group
Group type: COMPARATOR
Intervention: Above-elbow cast (AEC)
Number of subjects: 66
Study 20942286 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture (at Hegu (LI 4), Waiguan (TE 5), Jinmen (BL 63), Taichong (LR 3), Zusanli (ST 36), Qiuxu (GB 40)) during anesthesia
Number of subjects: 80
Study 20942286 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 80
Study 20942286 — intervention group
Group type: COMPARATOR
Intervention: Control group (no electroacupuncture)
Number of subjects: 80
Study 17906008 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose E2/levonorgestrel (0.023 mg/d 17beta-estradiol and 0.0075 mg/d levonorgestrel)
Number of subjects: 425
Study 17906008 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-dose E2 (0.014 mg/d 17beta-estradiol)
Number of subjects: 425
Study 17906008 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-dose E2
Number of subjects: 425
Study 17906008 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 425
Study 15772925 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.27% glucose dialysis solution
Number of subjects: 23
Study 15772925 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.86% glucose dialysis solution
Number of subjects: 23
Study 11893366 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate (400 mg administered daily for 6 weeks)
Number of subjects: 18
Study 11893366 — intervention group
Group type: COMPARATOR
Intervention: Normolipidemic controls
Number of subjects: 18
Study 9916601 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil citrate 25 mg
Number of subjects: 100
Study 9916601 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil citrate 50 mg
Number of subjects: 100
Study 9916601 — intervention group
Group type: COMPARATOR
Intervention: Sildenafil citrate 100 mg
Number of subjects: 100
Study 9916601 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 7842147 — intervention group
Group type: EXPERIMENTAL
Intervention: Nortriptyline hydrochloride prescribed by primary care physicians trained in clinical guidelines
Number of subjects: 91
Study 7842147 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation phase of treatment with antidepressant medication
Number of subjects: 91
Study 7842147 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressant medication as per AHCPR guidelines
Number of subjects: 91
Study 2221313 — intervention group
Group type: COMPARATOR
Intervention: Thiopentone 3‐6 mg/kg
Number of subjects: 75
Study 2221313 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1‐3 mg/kg mixed with lignocaine (10/200 mg)
Number of subjects: 75
Study 2221313 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol 1‐3 mg/kg followed by alfentanil 0.01 mg/kg
Number of subjects: 75
Study 750185 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg suppository
Number of subjects: 201
Study 750185 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg suppository
Number of subjects: 201
Study 31740726 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS group
Number of subjects: 38
Study 31740726 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 38
Study 31290589 — intervention group
Group type: EXPERIMENTAL
Intervention: bleached for 45 min, treated with sodium ascorbate (SA) for 2 min, and bonded
Number of subjects: 70
Study 31290589 — intervention group
Group type: EXPERIMENTAL
Intervention: bleached for 12 days, treated with SA for 10 min, and bonded
Number of subjects: 70
Study 31290589 — intervention group
Group type: EXPERIMENTAL
Intervention: bleached for 45 min, bonded immediately
Number of subjects: 70
Study 31290589 — intervention group
Group type: EXPERIMENTAL
Intervention: bleached for 12 days, bonded immediately
Number of subjects: 70
Study 31290589 — intervention group
Group type: EXPERIMENTAL
Intervention: bleached for 45 min, bonded after 2 weeks
Number of subjects: 70
Study 31290589 — intervention group
Group type: EXPERIMENTAL
Intervention: bleached for 12 days, bonded after 2 weeks
Number of subjects: 70
Study 31290589 — intervention group
Group type: EXPERIMENTAL
Intervention: etch-and-rinse mode
Number of subjects: 70
Study 31290589 — intervention group
Group type: EXPERIMENTAL
Intervention: self-etch mode
Number of subjects: 70
Study 31290589 — intervention group
Group type: COMPARATOR
Intervention: control (unbleached)
Number of subjects: 70
Study 29297555 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% TiF4‐gel applied once (TiF41)
Number of subjects: 72
Study 29297555 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% TiF4‐gel applied twice (TiF42)
Number of subjects: 72
Study 29297555 — intervention group
Group type: EXPERIMENTAL
Intervention: 4% TiF4‐gel applied three times (TiF43)
Number of subjects: 72